ASCITES HEPATIC
Clinical trials for ASCITES HEPATIC explained in plain language.
Never miss a new study
Get alerted when new ASCITES HEPATIC trials appear
Sign up with your email to follow new studies for ASCITES HEPATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New stent trick may prevent brain fog after liver shunt surgery
Disease control Recruiting nowThis study tests a new way to place a stent (a small tube) in the liver to treat serious complications of cirrhosis, like bleeding or fluid buildup. The new technique uses a smaller balloon to keep the stent slightly narrow at first, which may lower the risk of a brain condition …
Matched conditions: ASCITES HEPATIC
Phase: NA • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated May 26, 2026 05:33 UTC
-
New shunt study aims to boost survival in liver patients with severe swelling
Disease control Recruiting nowThis study compares a procedure called TIPS (a shunt that reroutes blood in the liver) against standard treatments like water pills and fluid drainage for people with liver cirrhosis who have developed ascites (fluid buildup in the belly). The goal is to see if early TIPS placeme…
Matched conditions: ASCITES HEPATIC
Phase: NA • Sponsor: University Hospital Freiburg • Aim: Disease control
Last updated May 26, 2026 05:31 UTC
-
New stent could help control liver cirrhosis complications
Disease control Recruiting nowThis study is testing a device called the LIVERTY TIPS stent graft in 166 people with cirrhosis and related high blood pressure in the liver. The goal is to see if the stent stays open and helps control problems like internal bleeding or fluid buildup in the belly. Participants w…
Matched conditions: ASCITES HEPATIC
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New drug hopes to tame scarred livers
Disease control Recruiting nowThis study tests an experimental drug called PHIN-214 in 74 adults with mild-to-moderate liver cirrhosis (Child-Pugh A or B). The goal is to find a safe dose and see how the body handles the drug. It is an early-phase trial focused on safety, not a cure.
Matched conditions: ASCITES HEPATIC
Phase: PHASE1 • Sponsor: PharmaIN • Aim: Disease control
Last updated May 15, 2026 11:55 UTC